OHSU Cancer Institute to Use Sequenom's MassARRAY Technology for Cancer Research

Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced that Portland, Ore.-based Oregon Health & Science University (OHSU) Cancer Institute has purchased a MassARRAY(R) system for use in the discovery, development and testing of biomarker panels for rapid classification and characterization of cancer. The OHSU Cancer Institute is recognized worldwide for its cancer research.

Source: Sequenom